Pages that link to "Item:Q2286039"

The following pages link to A mathematical model of tumor-immune interactions with an immune checkpoint inhibitor (Q2286039):

Displaying 21 items.

• B7-H1 and a mathematical model for cytotoxic T cell and tumor cell interaction (Q417323) (← links)
• Longtime behavior of a class of stochastic tumor-immune systems (Q826810) (← links)
• Stability and Hopf bifurcations in a competitive tumour-immune system with intrinsic recruitment delay and chemotherapy (Q1981174) (← links)
• Mathematical modeling of an immune checkpoint inhibitor and its synergy with an immunostimulant (Q2033441) (← links)
• Mathematical modeling for the combination treatment of IFN-\(\gamma\) and anti-PD-1 in cancer immunotherapy (Q2103601) (← links)
• Cancer therapy with immune checkpoint inhibitor and CSF-1 blockade: a mathematical model (Q2109247) (← links)
• Mathematical modelling of the inhibitory role of regulatory T cells in tumor immune response (Q2205364) (← links)
• Mathematical model for delayed responses in immune checkpoint blockades (Q2239292) (← links)
• Mathematical modeling of cancer treatment with radiation and PD-L1 inhibitor (Q2303919) (← links)
• Modeling LSD1-mediated tumor stagnation (Q2659798) (← links)
• MATHEMATICAL MODELING OF <i>IN-VIVO</i> TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS (Q4628893) (← links)
• On a discrete model of tumour–immune system interactions with blockade of immune checkpoints (Q5037845) (← links)
• Dynamical Analysis of a Melanoma Model with Immune Response (Q5094765) (← links)
• ANTI-TUMOR IMMUNITY AND TUMOR ANTI-IMMUNITY IN A MATHEMATICAL MODEL OF TUMOR IMMUNOTHERAPY (Q5468606) (← links)
• DYNAMICAL BEHAVIORS OF A CLASS OF STOCHASTIC TUMOR–IMMUNE SYSTEMS (Q6090078) (← links)
• Investigating the synergistic effects of immunotherapy and normalization treatment in modulating tumor microenvironment and enhancing treatment efficacy (Q6130759) (← links)
• A model of tumor‐immune system interactions with healthy cells and immunotherapies (Q6139688) (← links)
• Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma (Q6147712) (← links)
• Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study (Q6174314) (← links)
• Bifurcations of a cancer immunotherapy model explaining the transient delayed response and various other responses (Q6551766) (← links)
• Mathematical modeling of tumor immune interactions: the role of anti-FGFR and anti-PD-1 in the combination therapy (Q6597999) (← links)